MedPath

Bupropion Hydrochloride

These highlights do not include all the information needed to use BUPROPION HYDROCHLORIDE extended-release tablets (XL) safely and effectively. See full prescribing information for BUPROPION HYDROCHLORIDE extended-release tablets (XL). BUPROPION HYDROCHLORIDE extended-release tablets (XL), for oral use Initial U.S. Approval: 1985

Approved
Approval ID

16a788ff-8bd5-4f70-a3fd-a89db019e435

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 3, 2022

Manufacturers
FDA

RADHA PHARMACEUTICALS, INC.

DUNS: 117634222

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

bupropion hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code77771-144
Application NumberANDA207479
Product Classification
M
Marketing Category
C73584
G
Generic Name
bupropion hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateNovember 3, 2022
FDA Product Classification

INGREDIENTS (13)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
COPOVIDONE K25-31Inactive
Code: D9C330MD8B
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE AInactive
Code: NX76LV5T8J
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
TRIETHYL CITRATEInactive
Code: 8Z96QXD6UM
Classification: IACT
BUPROPION HYDROCHLORIDEActive
Quantity: 150 mg in 1 1
Code: ZG7E5POY8O
Classification: ACTIB
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT

bupropion hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code77771-145
Application NumberANDA207479
Product Classification
M
Marketing Category
C73584
G
Generic Name
bupropion hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateNovember 3, 2022
FDA Product Classification

INGREDIENTS (13)

COPOVIDONE K25-31Inactive
Code: D9C330MD8B
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE AInactive
Code: NX76LV5T8J
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
TRIETHYL CITRATEInactive
Code: 8Z96QXD6UM
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
BUPROPION HYDROCHLORIDEActive
Quantity: 300 mg in 1 1
Code: ZG7E5POY8O
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.